DE69012388T2 - Selektive Adenosinrezeptor-Verbindungen. - Google Patents

Selektive Adenosinrezeptor-Verbindungen.

Info

Publication number
DE69012388T2
DE69012388T2 DE69012388T DE69012388T DE69012388T2 DE 69012388 T2 DE69012388 T2 DE 69012388T2 DE 69012388 T DE69012388 T DE 69012388T DE 69012388 T DE69012388 T DE 69012388T DE 69012388 T2 DE69012388 T2 DE 69012388T2
Authority
DE
Germany
Prior art keywords
adenosine receptor
selective adenosine
receptor compounds
compounds
selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69012388T
Other languages
English (en)
Other versions
DE69012388D1 (de
Inventor
Norton P Peet
Nelsen L Lentz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69012388D1 publication Critical patent/DE69012388D1/de
Publication of DE69012388T2 publication Critical patent/DE69012388T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DE69012388T 1989-03-29 1990-03-28 Selektive Adenosinrezeptor-Verbindungen. Expired - Fee Related DE69012388T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33040089A 1989-03-29 1989-03-29

Publications (2)

Publication Number Publication Date
DE69012388D1 DE69012388D1 (de) 1994-10-20
DE69012388T2 true DE69012388T2 (de) 1995-04-27

Family

ID=23289598

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69012388T Expired - Fee Related DE69012388T2 (de) 1989-03-29 1990-03-28 Selektive Adenosinrezeptor-Verbindungen.

Country Status (18)

Country Link
EP (1) EP0390111B1 (de)
JP (1) JP3014000B2 (de)
KR (1) KR0150635B1 (de)
CN (1) CN1029972C (de)
AR (1) AR245720A1 (de)
AT (1) ATE111466T1 (de)
AU (1) AU623755B2 (de)
CA (1) CA2013381C (de)
DE (1) DE69012388T2 (de)
ES (1) ES2063851T3 (de)
FI (1) FI95133C (de)
HU (1) HU203349B (de)
IE (1) IE63545B1 (de)
IL (1) IL93893A (de)
NO (1) NO173997C (de)
NZ (1) NZ233077A (de)
PT (1) PT93589B (de)
ZA (1) ZA902282B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69033614T2 (de) * 1989-10-20 2001-04-19 Kyowa Hakko Kogyo Kk Kondensierte Purinderivate
NZ238609A (en) * 1990-06-21 1993-12-23 Schering Corp Polycyclic guanine derivatives; preparation, pharmaceutical compositions,
DE19629378A1 (de) * 1996-07-20 1998-01-29 Boehringer Ingelheim Kg Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE60018216T2 (de) * 1999-12-24 2006-02-16 Kyowa Hakko Kogyo Co., Ltd. Kondensierte purinderivate

Also Published As

Publication number Publication date
FI95133C (fi) 1995-12-27
NO173997B (no) 1993-11-22
HU203349B (en) 1991-07-29
FI95133B (fi) 1995-09-15
FI901550A0 (fi) 1990-03-28
KR900014390A (ko) 1990-10-23
HUT54160A (en) 1991-01-28
NZ233077A (en) 1992-12-23
ES2063851T3 (es) 1995-01-16
EP0390111A2 (de) 1990-10-03
NO901424D0 (no) 1990-03-28
CN1029972C (zh) 1995-10-11
ATE111466T1 (de) 1994-09-15
PT93589B (pt) 1996-06-28
CA2013381C (en) 2000-06-20
EP0390111A3 (de) 1991-05-08
KR0150635B1 (ko) 1998-10-15
NO901424L (no) 1990-10-01
JP3014000B2 (ja) 2000-02-28
AU623755B2 (en) 1992-05-21
EP0390111B1 (de) 1994-09-14
AU5218290A (en) 1990-10-04
IL93893A (en) 1994-07-31
IE901142L (en) 1990-09-29
DE69012388D1 (de) 1994-10-20
IL93893A0 (en) 1990-12-23
CA2013381A1 (en) 1990-09-29
NO173997C (no) 1994-03-02
HU901857D0 (en) 1990-08-28
CN1045974A (zh) 1990-10-10
PT93589A (pt) 1990-11-20
AR245720A1 (es) 1994-02-28
JPH02289574A (ja) 1990-11-29
ZA902282B (en) 1990-12-28
IE63545B1 (en) 1995-05-17

Similar Documents

Publication Publication Date Title
MX9203215A (es) Nucleosidos terapeuticos.
FI906242A0 (fi) Selektiv esterifiering av laongkedade fettsyramonoglycerider med medellaongkedade fettsyraanhydrider.
FI902165A0 (fi) Selektivt fungerande taendare.
NO903190D0 (no) Forbedret sukrose-6-ester-klorering.
NO900814L (no) Borkrone.
DE69022750T2 (de) Bohrgerät.
NO890253L (no) Dideoksydidehydrokarbocykliske nukleosider.
FI895317A0 (fi) System foer byggklotsar.
DE3888530D1 (de) 3'-Azido-2',3'-dideoxynucleosid-5'-phosphonate.
DK0449175T3 (da) Selektive adenosinreceptormidler
NO900662D0 (no) Borkrone.
FI890691A0 (fi) Makroporoesa selektiva jonbytarhartser.
FI920987A0 (fi) Interleukin-4-receptor.
DE69012388D1 (de) Selektive Adenosinrezeptor-Verbindungen.
NO900303L (no) Hoeytrykk-tetningssystem.
NO893260L (no) Forskalingssystem.
FI955257A (fi) 8-substituoidut-ksantiinit valikoivina adenosiinireseptoriaineina
FI895448A (fi) Antennsystem foer fordon.
BR9007147A (pt) Oxabicicloalcanos seletivos
DE59005907D1 (de) Bordnetz.
NO904507L (no) Skillevegg.
FI924789A (fi) Gamma-interferoners loesliga, stympade receptor
DK218789A (da) Receptorantagonister
FI895480A0 (fi) Styv takkonstruktion.
DE387451T1 (de) Atherektomiesystem.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERRELL PHARMACEUTICALS INC. (N.D.GES.D. STAATES D

8339 Ceased/non-payment of the annual fee